Processa Pharmaceuticals, Inc. (PCSA)
2.16
+0.10
(+4.85%)
USD |
NASDAQ |
Sep 08, 16:00
2.16
0.00 (0.00%)
Pre-Market: 20:00
Processa Pharmaceuticals Total Assets (Quarterly) : 2.070M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.070M |
| March 31, 2026 | 4.521M |
| December 31, 2025 | 7.814M |
| September 30, 2025 | 7.585M |
| June 30, 2025 | 8.182M |
| March 31, 2025 | 4.810M |
| December 31, 2024 | 3.229M |
| September 30, 2024 | 4.942M |
| June 30, 2024 | 7.601M |
| March 31, 2024 | 9.945M |
| December 31, 2023 | 5.787M |
| September 30, 2023 | 8.083M |
| June 30, 2023 | 10.09M |
| March 31, 2023 | 12.43M |
| December 31, 2022 | 8.620M |
| September 30, 2022 | 18.60M |
| June 30, 2022 | 21.66M |
| March 31, 2022 | 24.30M |
| December 31, 2021 | 28.61M |
| September 30, 2021 | 29.03M |
| June 30, 2021 | 31.14M |
| March 31, 2021 | 33.34M |
| December 31, 2020 | 27.12M |
| September 30, 2020 | 9.589M |
| June 30, 2020 | 10.01M |
| Date | Value |
|---|---|
| March 31, 2020 | 10.01M |
| December 31, 2019 | 12.00M |
| September 30, 2019 | 10.82M |
| June 30, 2019 | 12.71M |
| March 31, 2019 | 13.76M |
| December 31, 2018 | 15.01M |
| September 30, 2018 | 15.26M |
| June 30, 2018 | 16.24M |
| March 31, 2018 | 12.89M |
| December 31, 2017 | |
| September 30, 2017 | 0.0803M |
| June 30, 2017 | 0.0019M |
| March 31, 2017 | 0.0016M |
| December 31, 2016 | 0.0032M |
| September 30, 2016 | 0.0352M |
| June 30, 2016 | 0.0435M |
| March 31, 2016 | 0.0473M |
| December 31, 2015 | |
| September 30, 2015 | 0.4981M |
| June 30, 2015 | 0.8777M |
| March 31, 2015 | 2.543M |
| December 31, 2014 | 2.542M |
| September 30, 2014 | 2.667M |
| June 30, 2014 | 2.785M |
| March 31, 2014 | 2.908M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.387M |
| Shareholders Equity (Quarterly) | -0.3173M |
| Current Ratio | 0.8657 |
| Net Debt Paydown Yield | 0.19% |